metatinib
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2013 (NCT02004548)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
KDR inhibitor
- Hepatocyte growth factor receptorINHIBITOR
MET inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- metatinib tromethamine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02650375 | Phase 1 | Oct 1, 2015 | Sichuan University, Simcere Pharmaceutical Co., Ltd |
| NCT02004548 | Phase 1 | May 1, 2013 | Sichuan University, Simcere Pharmaceutical Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sichuan University | Academic/Hospital | 2 | 0 | 1 | 2013 |
| Simcere Pharmaceutical Co., Ltd | For profit | 2 | 2 | 1 | 2013 |
2 organizations
Page 1 / 1